Mirage News1 小时
Bispecific Antibody Boosts NK Cell Response in Lymphoma
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...
Technology Networks10 小时
Novel Cell Therapy Yields Promising Response Rates in Lymphoma Patients
A novel cell therapy approach using natural killer cells pre-complexed with a bispecific antibody, was safe and generated ...
Targeted Oncology20 小时
Popat Covers Itacitinib and GVHD Prevention Trial Results
Uday R. Popat, MD, discusses promising findings from a phase 2 trial evaluating the JAK inhibitor itacitinib combined with ...